Upfront Diagnostics Announces Global Medical Advisory Board to Accelerate Efforts in Reducing Time to Stroke Care

Contributed by: GlobeNewswire

Tags

Stroke Care

More Like This

UpFront Diagnostics Announces CE Mark Approval for LVOne — the World's First Rapid Blood Test to Diagnose Stroke

PR Newswire associated0

Medtech Startup AI-Stroke Raises $4.6 Million to Bring Artificial Intelligence to Pre-CT Emergency Stroke Care

Advances in science set to transform treatments for people living with dementia

LifeArc and Global Alzheimer's Platform Foundation - Scientists test whether a finger prick blood test could be used to help diagnose Alzheimer's disease before symptoms begin

Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics

New Blood Test Helps GPs Manage Brain Scan Delays, Brings Field Forward

Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays

Fujirebio Expands Access to Blood-based Neurology Testing in Brazil with ANVISA Market Authorization for Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma